Antinuclear Antibody Positivity in Patients With Hair Loss After COVID-19 Infection

INTRODUCTION: Hair loss is one of the most common disorders after coronavirus disease 2019 (COVID-19) infection. This study aimed to investigate the relationship between COVID-19-related hair loss and antinuclear antibody (ANA) positivity and patterns. METHODS: ANA positivity and patterns were analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Manav, Vildan, Erdil, Duygu, Koku Aksu, Ayşe Esra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188190/
https://www.ncbi.nlm.nih.gov/pubmed/37196298
http://dx.doi.org/10.5826/dpc.1302a81
Descripción
Sumario:INTRODUCTION: Hair loss is one of the most common disorders after coronavirus disease 2019 (COVID-19) infection. This study aimed to investigate the relationship between COVID-19-related hair loss and antinuclear antibody (ANA) positivity and patterns. METHODS: ANA positivity and patterns were analyzed in 30 female COVID-19 patients with hair loss complaints and compared in terms of the presence of autoimmunity between patients with and without COVID-19 exhibiting hair loss. RESULTS: ANA positivity and cytoplasmic patterns were detected in 40% of the patients with COVID-19 infection and hair loss. Trichodynia and diffuse hair loss were observed in 63.3% and 53.3%, respectively. CONCLUSIONS: In patients with COVID-19-related hair loss, diffuse hair loss and ANA positivity may be related to the high antibody levels triggered by COVID-19 infection.

Ejemplares similares